Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer.

Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer.

Conventional high-grade osteosarcoma is the most common primary bone malignancy. Although altered expression of the p53 inhibitor HDMX (Mdmx/Mdm4) is associated with cancer risk, progression, and outcome in other tumor types, little is known about its role in osteosarcoma. High expression of the Hdm...

Full description

Bibliographic Details
Main Authors:	Lenos, K, Grawenda, A, Lodder, K, Kuijjer, M, Teunisse, A, Repapi, E, Grochola, L, Bartel, F, Hogendoorn, P, Wuerl, P, Taubert, H, Cleton-Jansen, A, Bond, G, Jochemsen, A
Format:	Journal article
Language:	English
Published:	2012

Similar Items

A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.
by: Yee, K, et al.
Published: (2012)

Single-nucleotide polymorphisms in the p53 signaling pathway.
by: Grochola, L, et al.
Published: (2010)

The identification and analysis of molecular biomarkers in the p53 tumour suppressor pathway that affect cancer progression in humans
by: Grawenda, A, et al.
Published: (2013)

Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival.
by: Vazquez, A, et al.
Published: (2010)

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.
by: Bond, G, et al.
Published: (2004)

Activation of cAMP Signaling Interferes with Stress-Induced p53 Accumulation in ALL-Derived Cells by Promoting the Interaction between p53 and HDM2
by: Elin Hallan Naderi, et al.
Published: (2011-07-01)

The genetics of the p53 pathway, apoptosis and cancer therapy.
by: Vazquez, A, et al.
Published: (2008)

Zmat3 splices together p53-dependent tumor suppression
by: Kathryn T. Bieging-Rolett, et al.
Published: (2021-05-01)

P53
by: S. Kurilovich, et al.
Published: (2015-11-01)

p53’s Extended Reach: The Mutant p53 Secretome
by: Evangelos Pavlakis, et al.
Published: (2020-02-01)

Interaction of p53 with the Δ133p53α and Δ160p53α isoforms regulates p53 conformation and transcriptional activity
by: Fanny Tomas, et al.
Published: (2024-11-01)

The importance of p53 pathway genetics in inherited and somatic cancer genomes
by: Stracquadanio, G, et al.
Published: (2016)

OTUD5 regulates p53 stability by deubiquitinating p53.
by: Judong Luo, et al.
Published: (2013-01-01)

Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome.
by: Pellagatti, A, et al.
Published: (2010)

Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53
by: Lopez, C, et al.
Published: (2000)

Role of p53 serine 46 in p53 target gene regulation.
by: Leonie Smeenk, et al.
Published: (2011-01-01)

Analyze p53 degradation by 35S p53 Pulse Chase Analysis
by: Megan Astle, et al.
Published: (2012-11-01)

Rescuing the function of mutant p53.
by: Bullock, A, et al.
Published: (2001)

Inability of p53-reactivating compounds Nutlin-3 and RITA to overcome p53 resistance in tumor cells deficient for p53Ser46 phosphorylation
by: Teng, Ma, et al.
Published: (2012)

Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis
by: Hiraki, Masatsugu, et al.
Published: (2017)

Iron Metabolism Regulates p53 Signaling through Direct Heme-p53 Interaction and Modulation of p53 Localization, Stability, and Function
by: Jia Shen, et al.
Published: (2014-04-01)

MDMX in Cancer: A Partner of p53 and a p53-Independent Effector
by: Lin W, et al.
Published: (2024-01-01)

Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction.
by: Kelly M Thayer, et al.
Published: (2016-01-01)

JMCB Symposium 2019: The legend of p53 vs. cancer
by: Zhang, P, et al.
Published: (2019)

The rare nonsense mutation in p53 triggers alternative splicing to produce a protein capable of inducing apoptosis.
by: Evgeny M Makarov, et al.
Published: (2017-01-01)

Tanning, p53 and PCMR.
by: Goding, C
Published: (2008)

p53: Guardian of ploidy
by: Yael Aylon, et al.
Published: (2011-08-01)

Mechanism of Action p53
by: Ghorbat Saleh Ali
Published: (2023-03-01)

Recent Advances in p53
by: Gabriella D’Orazi
Published: (2021-02-01)

Stability of p53 homologs.
by: Tobias Brandt, et al.
Published: (2012-01-01)

Urodele p53 tolerates amino acid changes found in p53 variants linked to human cancer
by: Villiard Éric, et al.
Published: (2007-09-01)

Nucleophosmin and p14ARF mediated regulation of p53
by: Abraham, A
Published: (2015)

p53 activation by knockdown technologies.
by: Mara E Robu, et al.
Published: (2007-05-01)

Interaction of the p53 DNA-binding domain with its n-terminal extension modulates the stability of the p53 tetramer.
by: Natan, E, et al.
Published: (2011)

Mdm2 RING mutation enhances p53 transcriptional activity and p53-p300 interaction.
by: Hilary V Clegg, et al.
Published: (2012-01-01)

Constant rate of p53 tetramerization in response to DNA damage controls the p53 response
by: Giorgio Gaglia, et al.
Published: (2014-10-01)

Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest.
by: Julie Lafontaine, et al.
Published: (2012-01-01)

Specific recognition of p53 tetramers by peptides derived from p53 interacting proteins.
by: Ronen Gabizon, et al.
Published: (2012-01-01)

Suppression of p53 response by targeting p53-Mediator binding with a stapled peptide
by: Benjamin L. Allen, et al.
Published: (2022-04-01)

Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation
by: Li Ren Kong, et al.
Published: (2020-04-01)